These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30381397)

  • 1. Adapted ATPase domain communication overcomes the cytotoxicity of p97 inhibitors.
    Wei Y; Toth JI; Blanco GA; Bobkov AA; Petroski MD
    J Biol Chem; 2018 Dec; 293(52):20169-20180. PubMed ID: 30381397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved L464 in p97 D1-D2 linker is critical for p97 cofactor regulated ATPase activity.
    Zhang X; Gui L; Li S; Nandi P; Columbres RC; Wong DE; Moen DR; Lin HJ; Chiu PL; Chou TF
    Biochem J; 2021 Sep; 478(17):3185-3204. PubMed ID: 34405853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
    Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
    J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation.
    Caffrey B; Zhu X; Berezuk A; Tuttle K; Chittori S; Subramaniam S
    J Biol Chem; 2021 Oct; 297(4):101187. PubMed ID: 34520757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.
    Niwa H; Ewens CA; Tsang C; Yeung HO; Zhang X; Freemont PS
    J Biol Chem; 2012 Mar; 287(11):8561-70. PubMed ID: 22270372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive p97 Inhibitors for Potential Anticancer Therapy.
    Wang F; Li S; Gan T; Stott GM; Flint A; Chou TF
    ChemMedChem; 2020 Apr; 15(8):685-694. PubMed ID: 32162487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083.
    Tang WK; Odzorig T; Jin W; Xia D
    Mol Pharmacol; 2019 Mar; 95(3):286-293. PubMed ID: 30591537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
    Wang Q; Song C; Yang X; Li CC
    J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the catalytic D2 domain of the AAA+ ATPase p97 reveals a putative helical split-washer-type mechanism for substrate unfolding.
    Stach L; Morgan RM; Makhlouf L; Douangamath A; von Delft F; Zhang X; Freemont PS
    FEBS Lett; 2020 Mar; 594(5):933-943. PubMed ID: 31701538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the D1-D2 Linker of Human VCP/p97 in the Asymmetry and ATPase Activity of the D1-domain.
    Tang WK; Xia D
    Sci Rep; 2016 Jan; 6():20037. PubMed ID: 26818443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic flexibility of the ATPase p97 is important for its interprotomer motion transmission.
    Huang C; Li G; Lennarz WJ
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9792-7. PubMed ID: 22675116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.
    Trusch F; Matena A; Vuk M; Koerver L; Knævelsrud H; Freemont PS; Meyer H; Bayer P
    J Biol Chem; 2015 Dec; 290(49):29414-27. PubMed ID: 26475856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM structure of dodecamer human p97 in complex with NMS-873 reveals S
    Liu S; Ye X; Liu W; Liu L; Li D; Lin Q; Wang T
    Biochem Biophys Res Commun; 2022 Apr; 601():146-152. PubMed ID: 35247768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the AAA
    Rao MV; Williams DR; Cocklin S; Loll PJ
    J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane is Synergistic with CB-5083 and Inhibits Colony Formation of CB-5083-Resistant HCT116 Cells.
    Wang F; Li S; Rosencrans WM; Cheng KW; Stott GM; Mroczkowski B; Chou TF
    ChemMedChem; 2022 Jun; 17(11):e202200030. PubMed ID: 35451199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity.
    Song C; Wang Q; Li CC
    J Biol Chem; 2003 Feb; 278(6):3648-55. PubMed ID: 12446676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.
    Her NG; Toth JI; Ma CT; Wei Y; Motamedchaboki K; Sergienko E; Petroski MD
    Cell Chem Biol; 2016 Apr; 23(4):517-28. PubMed ID: 27105284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
    Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
    Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
    Lan B; Chai S; Wang P; Wang K
    Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VAT, the thermoplasma homolog of mammalian p97/VCP, is an N domain-regulated protein unfoldase.
    Gerega A; Rockel B; Peters J; Tamura T; Baumeister W; Zwickl P
    J Biol Chem; 2005 Dec; 280(52):42856-62. PubMed ID: 16236712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.